共 158 条
[1]
Kornbluth A(1998)Infliximab approved for use in Crohn's disease: a report on the FDA GI Advisory Committee conference Inflamm Bowel Dis 4 328-9
[2]
Hanauer SB(2002)Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial Lancet 359 1541-9
[3]
Feagan BG(2004)Remission in patients with Crohn's disease is associated with improvement in employment and quality of life and a decrease in hospitalizations and surgeries Am J Gastroenterol 99 91-6
[4]
Lichtenstein GR(2013)Infliximab reduces hospitalizations and surgery interventions in patients with inflammatory bowel disease: a systematic review and meta-analysis Inflamm Bowel Dis 19 2098-110
[5]
Mayer LF(2000)Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease Br J Surg. 87 1697-701
[6]
Schreiber S(1985)Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis Gastroenterology 88 1818-25
[7]
Colombel JF Rachmilewitz D(1986)Surgery for Crohn's disease in Ireland Dis Colon Rectum 29 230-3
[8]
Wolf DC(1998)Comparison of primary and reoperative surgery in patients with Crohns disease Ann Surg 227 492-5
[9]
Olson A(1976)Course and prognosis of Crohn's disease Gut 17 192-201
[10]
Bao W(2011)Surgery for adult Crohn's disease: what is the actual risk? Gut 60 1178-81